Recruiting
the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
cardiopulmonary exercise test evaluate patients with pulmonary hypertension before and after medical or balloon pulmonary angioplasty treatment
ClinicalTrials.gov IDNCT02061787
PhaseNot Applicable
Enrollment4000
SponsorChinese Pulmonary Vascular Disease Research Group
Age5 Years
SexALL
Conditions studied
Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder)
About this study
cardiopulmonary exercise test evaluate patients with pulmonary hypertension before and after medical or balloon pulmonary angioplasty treatment
Interventions
- Device: balloon pulmonary angioplasty — patients with chronic thromboembolic pulmonary hypertension who underwent balloon pulmonary angioplasty
Primary outcomes
- all cause mortality (5 years)
- mean pulmonary arterial pressure after treatment (5 years)
- achievement of low risk (5 years)
Eligibility information
Inclusion Criteria:
* pulmonary arterial hypertension;( WHO1)
* chronic thromboembolic pulmonary hypertension;
* pulmonary arterial hypertension due to other cause;
Exclusion Criteria:
* massive hemoptysis;
* unable to accomplish cardiopulmonary exercise testing due to neuromuscular disorders;
* recent recurrent syncope;
* pulmonary hypertension due to hypoxia;
* pulmonary hypertension due to left heart diseases.
Study locations
- center of pulmonary vascular disease, Fuwai hospital, Beijing, 100037 China
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.